Research Article: Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Introduction:
Hepatocellular carcinoma (HCC) is the most prevalent type of primary liver cancer ranking as the third leading cause of cancer-related death worldwide. Most HCC patients are often diagnosed at an advanced stage due to the insidious onset of this disease and patients frequently have comorbidities of chronic liver disease. This limitation limits the feasibility of curative treatments such as surgical resection, liver transplantation, and ablation. The corresponding practice guidelines recommend transarterial…
Read more